http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112755065-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4e82a5506a5b2996912d0f694a64daf2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-16 |
| filingDate | 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bf4eb1e68d1d2ca6908aedd9b300939 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2399e5755e469d9c4ee251fa226d10d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41397355293ebac7e19f4ef5537ea75a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e5a323fd03cb06ff025ceac6eaab775 |
| publicationDate | 2021-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112755065-A |
| titleOfInvention | Application of Yanqinglan |
| abstract | The invention discloses the application of Yanqinglan. The yanqinglan of the invention is used in the preparation of products for hangover or in the preparation of products for preventing and treating alcohol-induced liver damage. The present invention shows through experiments that the sobering time of Yanqinglan high, medium and low dose groups is significantly shortened, which proves that the Yanqinglan tea of the present invention has a certain hangover effect, and the effect is dose-dependent. The invention has protective effect on alcoholic liver injury, and it has different degrees of reducing effect on AST, TC and TG in the serum of alcoholic liver injury rats. This experiment provides the experimental basis for the clinical application of C. japonica, and lays a foundation for its further development and utilization. Its mechanism of action needs to be further studied. |
| priorityDate | 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 559.